The Nomination and Remuneration Committee of the Company approved on September 8, 2026:

  • Allotment of 2,344 equity shares of face value ₹2 each
  • Transfer of 54,749 equity shares of face value ₹2 each

These actions were executed under the Brainbees Employees Stock Option Plan 2022 (BBESOP 2022) through both cash exercise and cashless exercise methods for eligible employees. In cashless exercises, the Trust is authorized to sell shares on behalf of option holders to recover exercise price and tax amounts.

The newly allotted and transferred equity shares will rank pari-passu with existing equity shares of the Company.

Financial Impact

Consequent to this allotment, the Company's paid-up share capital has increased from ₹104,41,76,480 to ₹104,41,81,168.

ESOP Scheme Details (BBESOP 2022)

  • Options granted: The current allotment represents exercise of 2,344 options
  • Regulatory compliance: Scheme is in terms of SEBI SBEB Regulations, 2021
  • Exercise price: ₹2 per option
  • Options vested: 1,35,30,458 options (excluding shares exercised till date)
  • Options exercised: 2,344 through direct route
  • Money realized: ₹4,688
  • Options lapsed: 6,20,709
  • Diluted EPS: ₹0.413 post-allotment (calculated using Q1FY27 earnings)

Significant Terms

BBESOP 2022 provides for treatment of Stock Options in cases of death, permanent incapacity, resignation, termination, and retirement. Equity shares allotted/transferred pursuant to exercise are not subject to lock-in and rank pari-passu with existing shares.

Administrative Details

  • Date of share issue/allotment: September 8, 2026
  • Number of shares issued: 2,344
  • Distinctive numbers: 522088241 to 522090584
  • Total issued shares after issue: 52,20,90,584
  • Exercise price per share: ₹2
  • Premium per share: Nil

Regulatory Filings

The disclosure will be hosted on the Company's website at www.firstcry.com/investor-relations. The statement under regulation 10(b) of SEBI SBEB Regulations was previously filed with:

  • NSE on October 22, 2024 (Filing Number: 44801)
  • BSE on October 22, 2024 (Filing Number: 214518)

In-principle approvals were received from both exchanges on December 11, 2024.